Success Stories: With our help, a Scholar in the Field of Medicinal Chemistry Secures an NIW Petition Approval, Despite RFE

Client’s Testimonial:

“Thanks again for your wonderful work.”

On February 12^th, 2020, we received another NIW (National Interest Waiver) approval for an Investigator in the Field of Medicinal Chemistry (Approval Notice).

General Field: Medicinal Chemistry

Position at the Time of Case Filing: Scholar

Country of Origin: Sri Lanka

State of Residence at the Time of Filing: California

Approval Notice Date: February 12^th, 2020

Processing Time: 11 months, 23 days

Case Summary:

With a doctoral degree in chemistry, a scholar from Sri Lanka was a good fit for EB-2 NIW (National Interest Waiver). After a careful review of his credentials, we concluded that we could help him secure the national interest waiver, and these are the key points we focused on:

We reviewed and accounted for our client’s work on the development of techniques for the diagnosis and treatment of prostate and other forms of cancer. We demonstrated that his work is crucial to the US because it addresses the need for improved diagnostic and therapeutic techniques for detecting and treating cancer, a disease that is prevalent throughout North America and Europe. As early diagnosis and targeted treatments are believed to be the greatest indicators of successful fights against cancer, our client’s research is able to improve the survival rates of this globally prevalent and deadly disease.
We listed the 35 times his work was cited at the time of filing. We used this number to prove that our client’s publications are widely recognised and relied upon in the field of medicinal chemistry.
Our client’s publication record was also noted: 5 peer-reviewed journal articles (4 of them first-authored) and 1 U.S. patent. As these papers were published in the field’s top journals, they reflected our client’s influence in the field.
As with all our clients, we helped him select potential recommenders to support his case. Our client obtained 6 letters of recommendation, all from notable experts and influential researchers in the field. This is what one of them noted about our client and his work: “[Client’s] research therefore helps to make cancer treatments more effective and less demanding on patients, both of which are important goals for cancer therapy. Cancer remains one of the most pressing medical issues in developed countries around the world, and it is important that [client’s] research in this area go on without undue interruptions.”
We also listed the 10 times our client judged the work of his peers. As only top-level experts are invited to perform review work, our client’s review activity highlighted his important standing in the field.

Request for Evidence (RFE):

Despite our meticulous presentation of our client’s strong credentials, the USCIS issued a Request for Evidence (RFE). As soon as we received the RFE, our legal team sprang into action. We promptly responded to the RFE and successfully dealt with all hesitations about our client’s qualifications.

EB-2 NIW approval:

Overall, it was 11 months and 23 days before the USCIS approved our client’s EB-2 NIW case, and we are pleased that they ultimately granted approval. We congratulate our client on this milestone and wish him the best as he continues to advance the field of medicinal chemistry here in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.